Xenon Pharmaceuticals Inc.: Form 8-K, filed Jun 5, 2024
Filed with the SEC on Jun 5, 2024 and accepted by EDGAR at Jun 5, 2024, 20:12 ET.
Items reported
- Item 5.07 Shareholder vote results
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-24-069318. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.